ABI Launches Revolutionary 23WELL Ovary Care Capsules at Circle Harmony

ABI Launches Revolutionary Ovary Care Capsules at Circle Harmony in Shanghai

Shanghai, May 8, 2024 – Andall Biosciences Inc. (ABI) has made waves in the biotechnology industry with the launch of their groundbreaking new product line, 23WELL. The brand’s debut offering, Ovary Care Capsules (1+1), has taken center stage at Circle Harmony, a prestigious medical service institution located within InterContinental Shanghai Ruijin.

What sets 23WELL apart is its innovative approach to women’s health, specifically focusing on ovary care. The product has already received the Certificate of Free Sale from the U.S. Food and Drug Administration (FDA), showcasing ABI’s dedication to bridging the gap between therapeutic and preventative treatments for a healthier future.

Inspired by the 23 chromosomes that are the foundation of life, 23WELL combines cutting-edge life science research with natural ingredients to create practical health supplements that promote overall well-being. ABI’s commitment to excellence is evident in their meticulous selection of raw materials and the production of the capsules in a Class 100,000 GMP Cleanroom facility.

ABI has also applied for patents for their innovative method of preparing extracts in China, the United States, and the United Kingdom, solidifying their position as a leader in biotechnology. With 23WELL, ABI not only delivers premium quality products but also advocates for the pursuit of optimal health for all consumers.

The introduction of 23WELL Ovary Care Capsules marks a significant milestone for ABI and the biotechnology industry as a whole. With their focus on women’s health and commitment to innovation, ABI is set to revolutionize the way we approach preventative care and overall well-being.